MedTrace Logo

New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA)

NCT03068702 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2017-03-03

No results posted yet for this study

Summary

Sickle cell maculopathy was sparingly mentioned in the literature before despite the fact that sickle cell disease or sickle cell trait is common in people of many areas of the world. This study shows that OCTA is a very valuable, non invasive, office procedure that may well be used in diagnosing this disease.

Conditions

  • Sickle Cell Retinopathy

Interventions

DEVICE

Optical Coherence Tomography Angiography

Sponsors & Collaborators

  • Dr. S.S. Michel Clinic

    lead OTHER

Principal Investigators

  • shawkat s Michel, MD, FRCS Ed · Dr. S.S. Michel Clinic, 214 MHC, 156 street and 87 Ave, Edmonton, AB, Canada

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-21
Primary Completion
2017-01-12
Completion
2017-02-21

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03068702 on ClinicalTrials.gov